Conopco Inc. d/b/a Unilever – FDA 483, Jul 13, 2026
An FDA inspection of Conopco Inc. d/b/a Unilever in Raeford, NC, a drug manufacturer, revealed significant deficiencies in quality control, equipment maintenance, and record-keeping. The firm failed to adequately investigate consumer complaints and deviations, maintain equipment in good repair, establish proper cleaning validation procedures, and keep comprehensive equipment logs. These issues indicate a systemic lack of adherence to good manufacturing practices, posing potential risks to drug product quality and safety.
- Office
- Atlanta District Office
- Person
ID · 3337f69a-17ac-49c1-9272-4aa16bb8f157
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.